MRK Merck & Co
- 131.270
- +0.550+0.42%
About Merck & Co Company
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Company Profile
Company Executives
- Name
- Position
- Salary
- Robert M. Davis
- Chairman of the Board, President and Chief Executive Officer
- 20.27M
- David Michael Williams
- Executive Vice President and Chief Information and Digital Officer
- --
- Cristal N. Downing
- Executive Vice President and Chief Communications and Public Affairs Officer
- --
- Michael A Klobuchar
- Executive Vice President and Chief Strategy Officer
- --
- Caroline Litchfield
- Executive Vice President and Chief Financial Officer
- 8.30M
- Steven C. Mizell
- Executive Vice President and Chief Human Resources Officer
- --
- Chirfi Guindo
- Senior Vice President and Chief Marketing Officer, Human Health
- --
- Dalton E. Smart, III
- Senior Vice President, Finance, Global Controller and Principal Accounting Officer
- --
- Sanat Chattopadhyay
- Executive Vice President and President, Merck Manufacturing
- 6.24M
- Jannie Oosthuizen
- Senior Vice President and President, Merck U.S. Human Health
- --
- Richard R. DeLuca, Jr
- Executive Vice President and President, Merck Animal Health
- 6.20M
- Joseph Romanelli
- Senior Vice President and President, MSD, International Human Health
- --
- Dean Y. Li
- Executive Vice President and President, Merck Research Laboratories
- --
- Jennifer Zachary
- Executive Vice President, General Counsel and Corporate Secretary
- 4.56M
- Dean Y. Li
- President, Merck Research Laboratories
- 9.78M
- Dr. Risa J. Lavizzo-Mourey,M.D.
- Independent Director
- 365.00K
- Douglas M. Baker, Jr
- Independent Director
- 347.64K
- Mary Ellen Coe
- Independent Director
- 342.36K
- Inge G. Thulin
- Independent Director
- 340.00K
- Dr. Paul B. Rothman, M.D.
- Independent Director
- 380.00K
- Pamela J. Craig
- Independent Director
- 400.00K
- Kathy J. Warden
- Independent Director
- 350.00K
- Dr. Christine E. Seidman, M.D.
- Independent Director
- 350.00K
- Patricia F. Russo
- Independent Director
- 360.00K
- Dr. Stephen L. Mayo, PhD
- Independent Director
- 350.00K
- Thomas Henry Glocer
- Lead Independent Director
- 430.10K
- Peter C. Wendell
- Independent Director
- 370.00K
Analysis
Price Target
No Data
